BNHLF News 0.1980 Bioniche Life Scienc (BNHLF)

New Post Public Reply Private Reply Replies (0) Message Board

Apr 17, 2014 at 12:02 AM

Bioniche Life Scienc (BNHLF) 0.1980 $BNHLF

Bioniche Life Sciences Inc. Shareholders Approve Sale of Animal Health Business
PR Newswire - Mon Apr 14, 8:50AM CDT
Bioniche Life Sciences Inc. (TSX: BNC) today announced that its shareholders have voted in favour of the sale of the Company's Animal Health business to Vétoquinol SA.

Bioniche Life Sciences Inc. Continues to Execute on Strategic Review
PR Newswire - Thu Apr 03, 4:00PM CDT
Bioniche Life Sciences Inc. (TSX: BNC) today announced that it has successfully monetized two non-core properties for net proceeds in excess of $1 million.

ISS Recommends that Bioniche Shareholders Vote in Favour of Animal Health Sale Transaction
PR Newswire - Thu Apr 03, 10:00AM CDT
Bioniche Life Sciences Inc. (TSX: BNC) today announced that Institutional Shareholder Services (ISS) has recommended that shareholders vote FOR the special resolution pertaining to the sale of all of the Corporation's Animal Health business to Vétoquinol SA, to be considered at the upcoming Special Meeting of Shareholders:

Bioniche Life Sciences Inc. Holds Shareholder Conference Call/Webcast
PR Newswire - Thu Mar 13, 5:06PM CDT
Bioniche Life Sciences Inc. (TSX: BNC) today held a conference call and audio webcast for its shareholders, at which time, Company representatives provided several corporate updates. The corporate presentation used during today's call/webcast is available on the Company's website (www.Bioniche.com) under Investors - Corporate Presentations.

Bioniche Life Sciences Inc. Announces Key Corporate Updates
PR Newswire - Tue Mar 04, 8:00AM CST
Bioniche Life Sciences Inc. (TSX: BNC) announced today key corporate updates:

Vétoquinol to Acquire the Animal Health Business of Bioniche Life Sciences Inc.
PR Newswire - Thu Feb 27, 3:58PM CST
Vétoquinol (NYSE Euronext Paris: VETO) and Bioniche Life Sciences Inc. (TSX: BNC), today jointly announced their signing of a share purchase agreement under which Vétoquinol has agreed to purchase Bioniche's Animal Health business for the cash purchase price of CAD$61 million. This agreement remains subject to the approval by shareholders of Bioniche Life Sciences Inc., and the usual closing conditions for a transaction of this type. The Boards of Directors of both corporations have approved the binding agreement, and notice of a special Bioniche shareholder meeting will be forthcoming.

IIROC Trade Resumption - Bioniche Life Sciences Inc.
Newsfile Corp - Thu Feb 06, 11:56AM CST
Trading resumes in:

Bioniche Life Sciences Inc. Reports Fiscal 2014 Second Quarter Results and Announces Strategic Expenditure Review and New One Health Strategy
PR Newswire - Thu Feb 06, 11:47AM CST
(all figures are in Canadian dollars unless otherwise noted)

IIROC Trade Halt - Bioniche Life Sciences Inc.
Newsfile Corp - Thu Feb 06, 11:11AM CST
The following issues have been halted by IIROC:

Bioniche Life Sciences Inc. Appoints a Chief Operating Officer
PR Newswire - Tue Jan 07, 4:00PM CST
Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a leading clinical stage biotechnology company, today announced the appointment of Donald Olds as Chief Operating Officer, effective immediately.

Bioniche Life Sciences Inc. Delisting Approved by the ASX
PR Newswire - Wed Dec 11, 4:00PM CST
Bioniche Life Sciences Inc. (TSX: BNC, ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announces that the Australian Securities Exchange (ASX) has approved the Company's application to delist from the official list of the ASX subject to certain usual conditions.

Primary and Long-Term Illness Related to E. coli O157 Costs $403.9 Million per Year in Canada
PR Newswire - Wed Dec 04, 4:00PM CST
Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that a study approved for publication in the Journal of Food Protection demonstrates that Verotoxigenic Escherichia coli (VTEC) results in a cost of $403.9 million per year in Canada related to primary infections and long-term health outcomes. More than 93% of the VTEC infections are caused by the O157 strain of E. coli, and Bioniche One Health has developed a cattle vaccine to reduce the burden of this pathogen.

Bioniche Life Sciences Inc. Horse Product Approved for Sale in the U.S.
PR Newswire - Sun Dec 01, 4:00PM CST
a purified hyaluronate sodium I.V./I.A. product for horses-

Bioniche Life Sciences Inc. Reports Fiscal 2014 First Quarter Results
PR Newswire - Tue Nov 05, 7:25PM CST
(all figures are in Canadian dollars unless otherwise noted)

Bioniche Life Sciences Inc. Announces the Appointment of a New Chief Executive Officer
PR Newswire - Mon Nov 04, 7:30AM CST
Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that it has hired Dr. Michael Berendt as its new CEO effective immediately. Dr. Berendt replaces Mr. Graeme McRae in this role. Earlier this year, Mr. McRae announced his intention to retire and assume the role of Founder and Chairman Emeritus of the Company's Board of Directors.

Bioniche Management Proxy Circular for 2013 Annual and Special Meeting Now Available
PR Newswire - Fri Oct 18, 4:00PM CDT
Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that it has posted on the Company's website (www.Bioniche.com), on SEDAR www.sedar.com, and on www.ASX.com.au the management proxy circular relating to the Annual and Special Meeting of Bioniche Life Sciences Inc. Shareholders. The notice of meeting and management information circular (the "Circular"

has been mailed to all shareholders of record as at September 9, 2013.

Bioniche Life Sciences Inc. and Concerned Shareholders Announce a Settlement
PR Newswire - Wed Sep 11, 1:13PM CDT
new Board to oversee sale of Animal Health and sale/partnering of VMC with commitment to return capital to shareholders -

Bioniche Founder and CEO Announces his New Role with the Company
PR Newswire - Wed Sep 11, 11:03AM CDT
Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today issued an open letter to all shareholders from Founder, President & CEO, Graeme McRae, regarding his going forward role with the Company:

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Schneider Electric Pushes Water Management Tech at WEFTEC

Looks like Schneider Electric is diving headfirst into the choppy waters of utility management with its latest tech showcase at WEFTEC 2026. And trust me, the timing couldn't be more spot-on. With North America's water and wastewater systems groaning under the weight of aging infrastructure and cybersecurity threats, it’s about time someone brought something fresh to...

Nailah Thorbourne's Vlair Shapewear: Fashion Freedom

Fashion with a Punch: Nailah Thorbourne's New Venture You'd think from the way the fashion industry's been humming along that someone would've cracked the code on shapewear a long time ago, right? But alas, it takes Nailah Thorbourne to step out of Brick & Lace's spotlight and into this shapely market with Vlair Shapewear. Apparently, what most overlooked in comfort, she...

Appy Pie Secures Patent for AI Driven App Building

A New Dawn in App Creation You ever think about a world where creating an app is as straightforward as chatting with an old buddy? Well, that future's knocking at the door, courtesy of Appy Pie. They're ruffling feathers with a shiny new U.S. patent promising just that—apps whipped into shape by a bit of chitchat with their AI-powered platform. It's got folks scratching...

RiskScout Rides High on Funding, Tackles Financial Crime

A Fresh Injection to Combat Financial Crime Capital's flowing into RiskScout's coffers thanks to a new funding round, and it's not just about cash—it’s about gearing up for a battle against financial crime. The round was led by LiveOak Ventures, who aren't new to the block, alongside other players like Castle Creek Launchpad and Alloy Labs. After tripling their...

New Leadership at Newmark: Tech Focus Amplified

A Strategic Leap in Tech Leadership Newmark Group, Inc. (NASDAQ: NMRK) has handed the digital reins to Mike Whitaker, bringing him on board as Group Chief Information Officer. If you're in the loop with commercial real estate, this shakeup shouldn't come as a surprise. Newmark's been pretty gung-ho about tightening their tech playbook, and Whitaker's appointment is just...

Accuray, Samsung Push Boundaries with Imaging Deal

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Celina Graves Joins Expanding GoLive Streamers Platform

Celina Graves Breaks New Ground on GoLive Streamers You'd think television capture all the talent buzz, but nope. Celina Graves, known from her semifinalist run on America's Got Talent, is diving into new waters by joining GoLive Streamers. She's stirring up the scene by making her performances more personal, stretching beyond the flatness of your typical TV appearance....

AI Memory Growth Pushes Limits at GMIF2026 Summit

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

NUS Unveils eLuminator: A Leap for Robotics & Healthcare

Game-Changing Electronic Skin From NUS It's not every day you come across tech that could shake up multiple industries, but that's just what the National University of Singapore has cooked up with their latest brainchild—the eLuminator. This ain't your everyday wearable tech. We're talking a skin-like device that can both detect and show touch in real-time, no fiddly...

Perkins Rolls Out Mahjong to Revive Family Bonds

Perkins Ditches the Phones, Sparks True Connection No doubt about it, folks—Perkins Restaurant & Bakery has cooked up something special to bring families back to the table. Not just for pancakes or pies this time, but for a little classic game action with their limited-edition Mahjong set. Love it or leave it, this is Perkins tapping into the magic of togetherness...